Satori Capital Acquires Formulife; Brookside Capital Provides Financing Support
July 15, 2021
Satori Capital has acquired Formulife, a specialty contract manufacturer of custom-formulated nutritional supplements based in Allen, Texas. Brookside Capital Partners provided a unitranche debt facility and an equity co-investment to facilitate the transaction; Satori will use part of the investment to complete a major expansion of Formulife's production facility to more than double capacity and reduce customer lead times.
- Buyers
- Satori Capital, Brookside Capital Partners
- Targets
- Formulife
- Industry
- Food & Beverage
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Satori Capital Invests in Torani
January 18, 2022
Food & Beverage
Satori Capital has made a growth investment in beverage flavoring company Torani to support the brand's next phase of expansion. The investment will back direct-to-consumer growth, expanded distribution, new product innovation, and social impact initiatives including an employee stock ownership plan.
-
Danone Acquires Functional Formularies from Swander Pace Capital
May 1, 2024
Food & Beverage
Danone has acquired Functional Formularies, a provider of organic, whole-food, shelf-stable feeding tube formulas, from private equity firm Swander Pace Capital. Swander Pace had owned Functional Formularies since 2018 and invested in sales, innovation, and operations to grow the business; advisors on the transaction included Lazard and Jones Day.
-
BioSelective Capital Investments Acquires BioDuro's Irvine Drug Product Operations to Form Forma Life Sciences
February 4, 2026
Pharmaceuticals
BioSelective Capital Investments, together with Shayan Enterprises, LLC, acquired BioDuro’s drug product development and manufacturing operations in Irvine, California and formed Forma Life Sciences, Inc. The transaction transfers two U.S.-based oral solid dosage development and manufacturing facilities (≈65,000 sq ft and ≈40,000 sq ft) to the new Delaware-held company; BioDuro (an Advent portfolio company) sold the assets.
-
San Francisco Equity Partners Acquires Formula Corp
February 20, 2025
Manufacturing
San Francisco Equity Partners (SFEP) has acquired a majority stake in Formula Corp, a Washington-based formulator and contract manufacturer of cleaning products for consumer and professional end markets. Formula Corp co-founders Chas Werner and Alan Gangl will remain shareholders; Alexander Hutton acted as exclusive financial advisor to Formula Corp. SFEP said it will support Formula’s growth leveraging its experience building private-label and specialty manufacturing businesses focused on sustainable formulations and eco-friendly packaging.
-
Trive Capital Invests in Formula Wellness
March 18, 2024
Healthcare Services
Dallas-based private equity firm Trive Capital has made a growth investment in Formula Wellness, a medical-based wellness and med-spa operator focused on longevity, hormone balance, nutrition and aesthetics. The investment brings on a PE-backed management team to accelerate Formula Wellness's de novo expansion and add-on acquisition strategy across the DFW metroplex and beyond.
-
Linden Capital Partners Invests in Formulated Solutions
September 28, 2021
Healthcare Services
Chicago-based private equity firm Linden Capital Partners has invested in Formulated Solutions, a Largo, Florida CDMO that provides contract development and manufacturing services for OTC and Rx topical and nasal products. The investment was completed alongside current shareholders including the founding Dann Family and HealthEdge Investment Partners, with Linden principals joining the company's board and Twin Brook Capital Partners providing debt financing.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.